FABP5 explained

Fatty acid-binding protein, epidermal is a protein that in humans is encoded by the FABP5 gene.[1] [2]

Function

This gene encodes the fatty acid binding protein found in epidermal cells, and was first identified as being upregulated in psoriasis tissue. Fatty acid binding proteins are a family of small, highly conserved, cytoplasmic proteins that bind long-chain fatty acids and other hydrophobic ligands. It is thought that FABPs roles include fatty acid uptake, transport, and metabolism.[2]

The phytocannabinoids (THC and CBD) inhibit endocannabinoid anandamide (AEA) uptake by targeting FABP5, and competition for FABPs may in part or wholly explain the increased circulating levels of endocannabinoids reported after consumption of cannabinoids.[3] Results show that cannabinoids inhibit keratinocyte proliferation, and therefore support a potential role for cannabinoids in the treatment of psoriasis.[4]

Interactions

FABP5 has been shown to interact with S100A7.[5] [6]

Further reading

Notes and References

  1. Madsen P, Rasmussen HH, Leffers H, Honoré B, Celis JE . Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins . The Journal of Investigative Dermatology . 99 . 3 . 299–305 . September 1992 . 1512466 . 10.1111/1523-1747.ep12616641 .
  2. Web site: Entrez Gene: FABP5 fatty acid binding protein 5 (psoriasis-associated).
  3. Elmes MW, Kaczocha M, Berger WT, Leung K, Ralph BP, Wang L, Sweeney JM, Miyauchi JT, Tsirka SE, Ojima I, Deutsch DG . Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) . The Journal of Biological Chemistry . 290 . 14 . 8711–21 . April 2015 . 25666611 . 4423662 . 10.1074/jbc.M114.618447 . free .
  4. Wilkinson JD, Williamson EM . Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis . en . Journal of Dermatological Science . 45 . 2 . 87–92 . February 2007 . 17157480 . 10.1016/j.jdermsci.2006.10.009 .
  5. Ruse M, Broome AM, Eckert RL . S100A7 (psoriasin) interacts with epidermal fatty acid binding protein and localizes in focal adhesion-like structures in cultured keratinocytes . The Journal of Investigative Dermatology . 121 . 1 . 132–41 . July 2003 . 12839573 . 10.1046/j.1523-1747.2003.12309.x . free .
  6. Hagens G, Roulin K, Hotz R, Saurat JH, Hellman U, Siegenthaler G . Probable interaction between S100A7 and E-FABP in the cytosol of human keratinocytes from psoriatic scales . Molecular and Cellular Biochemistry . 192 . 1–2 . 123–8 . February 1999 . 10331666 . 10.1023/A:1006894909694 . 24171894 .